Nancy Torres Luna

Hematologist/Oncologist, BMT at Moffitt Cancer Center.

[ASTCT @ASTCT]

The latest ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy has been published in Transplantation and Cellular Therapy, providing a standardized framework for grading toxicities associated with immune effector cell therapies. ,The guidance maintains and clarifies grading for CRS and ICANS, introduces modified ICE (M-ICE) for children and patients with developmental delays, and addresses emerging toxicities including hematotoxicity, IEC-HS and non-ICANS neurotoxicities.
📖 Read the full guideline: https://t.co/hAJK4CurtE
@ASTCT_Journal

[Moffitt Cancer Center @MoffittNews]

Join us in marking a major milestone, our 10,000th blood and marrow transplant patient! From our first transplant in 1989 to becoming the largest program in the Southeast, Moffitt’s Blood and Marrow Transplant and Cellular Immunotherapy team has built a legacy of healing.

[ASH @ASH_hematology]

📢 Highlights of ASH® in Latin America | 25-26 abril | Punta del Este

🔬 Actualizaciones de la ASH Annual Meeting #ASH24
🩸 Sunset Session
📖 Meet & Greet con el Dr. Jorge Corte
🍽 Lunch with the Experts

¡Inscríbete! 🔗 https://t.co/eslbeH6PKX

#Hematología #Oncología

[Nancy Torres Luna @nancy_tle]

@DrR_DUNNE @NEJM Congrats Dr. Dunne!!

[Nancy Torres Luna @nancy_tle]

@DWallaceMD @DrCarlaCasulo @MelissaLoh21 Congrats!!

[Nancy Torres Luna @nancy_tle]

@PamChMD Ánimo Pame!!!! 💪🏼

[Nancy Torres Luna @nancy_tle]

@AnaVManana @ASCO @UCSFCancer @UCSFMedicine @ZSFGCare @rcmupr @KVanLoonMD @DrTFriedlander @ASCOTECAG @FernandoDiazMD1 @NarjustFlorezMD @drkomanduri Felicidades Ana!

[Nancy Torres Luna @nancy_tle]

@drtulsijose @StanfordCancer @StanfordDeptMed @hemeoncfellow @HemOncFellows @oncodaily @IMG_Oncologists @ASCOTECAG @ASH_hematology @HemOncWomenDocs @AMWADoctors @ACPIMPhysicians @IMG_MATCH Congrats! Enjoy!

[Nancy Torres Luna @nancy_tle]

@XimeJordan @Wimbledon Me too!!

[Nancy Torres Luna @nancy_tle]

@PamChMD @WomenInLymphoma @WomeninOnc @HemOncFellows @StoriesImg @ImgJourney @BrighamHeme @WeAllGrowLatina @LatContraCancer @AmericaDoctors @LatinxOncology Felicidades Pame!! 💪🏼💪🏼

[NEJM @NEJM]

Second tumors after CAR T-cell therapy are rare, and in one case of a secondary T-cell lymphoma, detailed analysis showed that the genetic construct that was used to make the CAR T cells was unrelated to the second tumor. Read the full study results: https://t.co/mxGSRyPgV2

[NEJM @NEJM]

Editorial: T-Cell Cancer after CAR T-Cell Therapy https://t.co/eCdArOtydc

[Nancy Torres Luna @nancy_tle]

@NicoGagelmann 🇵🇪

[Stanford Cancer Institute @StanfordCancer]

Thanks to the partnership with @StanfordMed Advanced Melanoma Program and @StanfordBMT_CT, Stanford treated the first #AdvancedMelanoma patient in the world with the newly approved #TILtherapy. https://t.co/YIAUqvwNuW #CellTherapy #TIL @DrBetofMDPhD #MelanomaAwarenessMonth

[Nancy Torres Luna @nancy_tle]

@COlazagasti @ASCO Congrats! Challenges with visas for imgs, especially as we transion out from fellowships, is a huge topic!

[Nancy Torres Luna @nancy_tle]

@AnaVManana @LatinasInMed @shakira @ChocoDoc11 @MomaVelez11 @BernabeCarolina @COlazagasti @csernatamayo_md 🙋🏻‍♀️!!!!

[Nancy Torres Luna @nancy_tle]

@drtulsijose @ASCO This is great.

[Nancy Torres Luna @nancy_tle]

@AliQosChi_MD @IBD_CeliacKids Que exito!! Felicidades 🥳

[Nancy Torres Luna @nancy_tle]

@NarjustFlorezMD Haha! This is very true!